Featured Research

from universities, journals, and other organizations

Immunology: Interleukin-21 Keeps Defense Cells In Good Trim

Date:
July 4, 2009
Source:
ETH Zurich
Summary:
Interleukin-21 plays a crucial role in fighting off chronic viral infections, scientists recently concluded. The discovery offers hope for specific treatments against HIV, hepatitis C and B, and tumors.

Interleukin-21 plays a crucial role in fighting off chronic viral infections, three research teams – including one at ETH Zurich – recently concluded. The topic inspired Science to publish three parallel papers in the Science Express. After all, the discovery offers hope for specific treatments against HIV, hepatitis C and B, and tumors.

Chronic viral diseases weaken the immune system: Instead of constantly fighting pathogens over a long period of time, it gives up somewhere along the line. Cytotoxic T lymphocytes (killer T cells), which kill off the infected cells, multiply more than ten-thousandfold during the early stages of a chronic viral disease. During the prolonged fight against the chronic viruses, however, they become exhausted and lose their defense capabilities, or even die off. In the case of HIV, this is the point where AIDS breaks out.

Killer T cells need IL-21

ETH-Zurich scientists from the group headed by Manfred Kopf, a professor at the Institute for Integrative Biology, conducted experiments in mice to find out what causes the killer T cells to crack. “We suspected it had something to do with interleukins”, explains Kopf. These naturally produced messengers of the immune systems control the growth, maturation, differentiation and death of immune cells. We currently know more than 60 of them with different characteristics.

The ETH-Zurich researchers focused on interleukin-21 (IL-21) in their experiments. They used mice that lacked receptors for interleukin-21 on the killer T cells, which meant that the cells were unable to respond to IL-21. The result of the experiment was that the mice were highly susceptible to chronic viral infection. The scientists showed increased exhaustion and death of killer T cells in mice lacking IL-21 receptors during chronic viral infection. The constant supply of IL-21 therefore appears to be crucial for the “fitness” of killer T cells and thus the entire immune system.

Helper T cells form IL-21

The researchers were also able to discover the source of IL-21: It is produced by the helper T lymphocytes (helper T cells). These immune cells support the killer T cells in the fight against chronic viruses. Kopf and his colleagues showed that IL-21 is only essential for defense against chronic viruses, but not for acute viral infections, such as influenza virus. Just how the interaction between helper T cells, Killer T cells and the virus works is still being investigated. Kopf’s team is especially interested in understanding the regulation of IL-21 and IL-21 receptor production during a chronic infection. The group will also look into the question as to whether the amount of IL-21 or the number of IL-21 receptors decides the progression of chronic viral diseases.

IL-21 as a treatment for chronic viral diseases?

The notion of boosting an immune system as it fights a chronic viral infection by giving it IL-21 seems to be the obvious solution. Whether an already exhausted immune system can be revitalized in this way remains unknown, however.

Naturally, the results arouse hopes for the treatment of chronic viral diseases in humans, such as HIV, and hepatitis C or B. IL-21 could also be relevant in combating tumors. After all, killer T cells also fight a long battle here aided by the T helper cells. “Before interleukin 21 can be considered for treatments against chronic viral infections, however, we have to check the extent to which the findings in the mouse model carry over to humans and their viral diseases”, says Kopf cautiously. At any rate, the researchers certainly won’t be short of work.

References:

Frφhlich A, et al. Science. Published online May 28, 2009. Doi: 10.1126/science.1172815

Elsaesser H, et al. Science. Published online May 7, 2009. Doi: 10.1126/science.1174182

Yi J, et al. Science. Published online May 14, 2009. Doi: 10.1126/science.1175194


Story Source:

The above story is based on materials provided by ETH Zurich. Note: Materials may be edited for content and length.


Cite This Page:

ETH Zurich. "Immunology: Interleukin-21 Keeps Defense Cells In Good Trim." ScienceDaily. ScienceDaily, 4 July 2009. <www.sciencedaily.com/releases/2009/06/090619090456.htm>.
ETH Zurich. (2009, July 4). Immunology: Interleukin-21 Keeps Defense Cells In Good Trim. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2009/06/090619090456.htm
ETH Zurich. "Immunology: Interleukin-21 Keeps Defense Cells In Good Trim." ScienceDaily. www.sciencedaily.com/releases/2009/06/090619090456.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins